ReviewCureus2025
Role of Inferior Turbinoplasty in Endoscopic Sinus Surgery: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Functional endoscopic sinus surgery (FESS) is widely used to treat chronic rhinosinusitis (CRS) and related sinonasal diseases, often performed alongside inferior turbinoplasty to improve symptoms. However, the added value of concurrent turbinoplasty remains unclear. This systematic review evaluates outcomes of FESS with and without inferior turbinoplasty. A systematic search of MEDLINE, Embase, and Cochrane databases was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. After screening, five studies comprising 4,619 patients met the inclusion criteria. Four studies assessed quality of life (QoL), all demonstrating postoperative improvement with both FESS alone and FESS plus inferior turbinoplasty. Only one study showed a significant QoL benefit with turbinoplasty; the others found no meaningful difference. One study evaluated olfaction and reported no significant impact from additional turbinoplasty. Revision surgery rates were not reported in any study. A paediatric study found no increased 30-day readmission risk associated with turbinoplasty. Concurrent inferior turbinoplasty with FESS appears safe and may offer benefit in select patient subgroups, such as those with nasal polyps. However, routine addition does not consistently improve overall QoL or olfactory outcomes. Further randomised controlled trials are required to clarify its clinical value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.